Five-Year Outcomes of Transcatheter or Surgical Aortic-Valve Replacement

2020783 citationsJournal Articlebronze Open Access

Authors

Raj Makkar · Cedars-Sinai Medical Center

Vinod H. Thourani · Piedmont Atlanta Hospital

Michael J. Mack · Baylor Scott & White Health

Susheel Kodali · Cardiovascular Institute of the South

Samir Kapadia · Cardiovascular Institute of the South

John G. Webb · St. Paul's Hospital

Sung‐Han Yoon

Abstract

Among patients with aortic stenosis who were at intermediate surgical risk, there was no significant difference in the incidence of death or disabling stroke at 5 years after TAVR as compared with surgical aortic-valve replacement. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).

Topics & Keywords

Cardiac Valve Diseases and Treatments Infective Endocarditis Diagnosis and Management Aortic Disease and Treatment Approaches

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 382, Issue 9, pp. 799-809

DOI: 10.1056/nejmoa1910555

Field-Weighted Citation Impact: 77.64